US equities |
MU $1,066.43 ▼-1.98% NVDA $236.09 ▼-0.58% PLTR $199.12 ▲+2.58% SNDK $1,641.24 ▼-3.02% AMD $636.30 ▼-1.48% INTC $109.67 ▼-3.05% META $721.33 ▲+0.00% SPCX $164.71 ▼-1.72%
FinancialContent

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

5.360 -0.070 (-1.29%)
Delayed Quote Updated: 10:06 AM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
24 25 Next >
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Levi Strauss Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Liquid Media Group Ltd. (NASDAQ: YVR) jumped 88.1% to $0.2719. 
Via Benzinga
News headline image
CNS Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
Via ACCESSWIRE
Study Finds Repeated Head Trauma Increases Brain Cancer Risk
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Adds Italy to Growing Portfolio of Countries for Berubicin Study
Via Investor Brand Network
News headline image
Why CNS Pharmaceuticals Shares Are Trading Higher ↗
CNS Pharmaceuticals Inc (NASDAQ: CNSP) shares are trading higher by 15.47% to $1.00 after the company announced it received approval from the Competent Authority and the central Ethics Committee in... 
Via Benzinga
News headline image
CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
Via ACCESSWIRE
Broad Cancer Analysis Finds Possibility for Tumor Reduction in Nearly All Cancers
Via Investor Brand Network
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 76 companies set new 52-week lows. 
Via Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces FY 2022 Results, Corporate Update
Via Investor Brand Network
AI Screens Brain Tumor Genes in Less Than Two Minutes
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in Upcoming Virtual Investor Event
Via Investor Brand Network
Lighting Up Malignant Tissues Could Boost Precision of Surgical Removal
Via Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Hits Key Milestone in Global GBM Clinical Trial with the Enrollment of First Patient in Spain
Via Investor Brand Network
Normalizing Blood Vessels in Tumors Could Improve Brain Cancer Immunotherapy
Via Investor Brand Network
Research Suggests Brain Cancers Could Be Detected Via Blood Tests
Via Investor Brand Network
Topics Death
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces It Has No Exposure to Silicon Valley Bank Issues
Via Investor Brand Network
Study Documents Dangers of Halting Opioid Treatments for Chronic Pain
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls First Patient in Switzerland in Potentially Pivotal Berubicin Trial
Via Investor Brand Network
News headline image
Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early... 
Via Benzinga
Researchers Find Ways to Ease Cancer Treatment Outcome Prediction
Via Investor Brand Network
New AI Tool Helps Personalize Breast Cancer Therapy
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 35 stocks hit new 52-week lows. 
Via Benzinga
Research Finds Most Pediatric Oncologists Don’t Discuss Prognosis with Caregivers
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls First Patient in Spain in Key Global Trial Studying Berubicin for Treatment of GBM
Via Investor Brand Network
Study Finds Boosting White Blood Cell Counts May Improve Treatment Outcomes
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Pleased with Early Results from Global Clinical Trial
Via Investor Brand Network
Study Determines That How Proteins Move May Influence Brain Tumor Growth
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses ‘Lifeblood’ of Phase 2 Berubicin Trial
Via Investor Brand Network
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
24 25 Next >